Literature DB >> 10918165

Trends in mortality from malignant melanoma in Sweden, 1970-1996.

G Cohn-Cedermark1, E Månsson-Brahme, L E Rutqvist, O Larsson, H Johansson, U Ringborg.   

Abstract

BACKGROUND: The rise in melanoma-related mortality in Sweden has been less pronounced than the increase in incidence. Interventional activities aimed at early detection may have contributed to this discrepancy.
METHODS: Individuals with malignant melanoma as the underlying cause of death between 1970 and 1996 (n = 7177) formed the basis of this study. Annual age-standardized mortality rates were calculated using the direct method of standardization with the Swedish population of 1970 as reference. Temporal trends in the standardized rates were evaluated using a log-linear model. The effects of age, period, and cohort on the mortality trends were estimated using a Poisson regression model.
RESULTS: Since the mid-1980s, melanoma-related mortality in Sweden has leveled off, with no further increase during the last 10-15 years. The contribution to the mortality from noncutaneous melanoma was proportionally stable (20-25%) during the studied period. In females, a significant decrease in mortality from cutaneous melanoma was shown for the period of 1987-1996 with an estimated annual decrease of -2.3% (95% confidence interval: -4.3 to -0.3). This trend appeared to be more pronounced in the Stockholm-Gotland region. The observed trends were best explained with the age-period model in both genders.
CONCLUSIONS: Melanoma-related mortality in Sweden has leveled off since the mid-1980s. During the period 1987-1996, a statistically significant downward trend was observed for females. This trend coincides with increased preventional activities. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Year:  2000        PMID: 10918165     DOI: 10.1002/1097-0142(20000715)89:2<348::aid-cncr20>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Validation of denaturing high performance liquid chromatography as a rapid detection method for the identification of human INK4A gene mutations.

Authors:  I Orlow; P Roy; A Barz; R Canchola; Y Song; M Berwick
Journal:  J Mol Diagn       Date:  2001-11       Impact factor: 5.568

2.  Metastatic melanoma positively influences pregnancy outcome in a mouse model: could a deadly tumor support embryo life?

Authors:  Rubens H Bollos; Mary U Nakamura; Valderez B V Lapchick; Estela M A F Bevilacqua; Mariangela Correa; Silvia Daher; Márcia M S Ishigai; Miriam G Jasiulionis
Journal:  Clin Exp Metastasis       Date:  2007-10-12       Impact factor: 5.150

3.  The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study.

Authors:  J Melia; S Moss; D Coleman; T Frost; R Graham-Brown; J A Hunter; R A Marsden; A du Vivier; A P Warin; J White; S M Whitehead; M A Wroughton
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

4.  Trends in mortality rates of cutaneous melanoma in East Asian populations.

Authors:  Ling Chen; Shaofei Jin
Journal:  PeerJ       Date:  2016-12-22       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.